In brief
U.S. District Judge Rita Lin has temporarily ordered the Trump administration to restore $500 million in federal grant funding that was frozen at UCLA. The ruling follows claims of civil rights violations related to antisemitism and affirmative action, stressing that the government failed to follow proper protocols for funding cuts. This decision is pivotal for various medical research grants that are crucial for public health advancements.
LOS ANGELES — A federal judge has ordered the Trump administration to restore $500 million in federal grant funding that it previously froze at the University of California, Los Angeles. U.S. District Judge Rita Lin issued a preliminary injunction stating that the government likely breached the Administrative Procedure Act by not providing specific reasons or procedures behind the funding cuts. Instead, the government had simply sent form letters to UCLA indicating that multiple grants were being suspended without elaborating on the terms.Earlier in August, UCLA reported that the administration halted approximately $584 million in federal grants over accusations linked to civil rights violations, primarily concerning antisemitism and affirmative action. Judge Lin had previously ruled in favor of UCLA following an $81 million grant restoration from the National Science Foundation that she determined had also violated initial orders regarding funding suspensions.The White House has yet to comment on this recent ruling.This decision reflects ongoing tensions regarding the Trump administration's control of federal funding aimed at driving reforms in higher education, which some perceive as an attempt to counteract perceived liberalism and promote re-evaluations of diversity, equity, and inclusion efforts.In cases like Harvard, where similar funding froze due to similar allegations, the judiciary has ruled that the funding interruptions constituted illegal retaliations against institutions that challenged administrative demands.Monday's ruling predominantly impacts hundreds of medical research grants from the National Institutes of Health, covering essential studies on neurological disorders and cancer. UCLA officials argue these funds are vital for advancing crucial health research vital to improving public health outcomes in the U.S.
